Modulation of Antithrombin-Protease Interactions by Semisynthetic Low-Molecular-Weight Heparins with Different Sulfation Patterns

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 6, 2003, Pages 661-670

  Sissi, Claudia ^a,b   Naggi, Annamaria ^a   Torri, Giangiacomo ^a   Palumbo, Manlio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

Author keywords

Antithrombin; Glycosaminoglycan; Heparin; Polysaccharide; Sulfation; Thrombin

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PROTEINASE; THROMBIN;

BINDING AFFINITY; COMPLEX FORMATION; DRUG PROTEIN BINDING; ENZYME ACTIVATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; SULFATION;

ANTITHROMBINS; ENDOPEPTIDASES; FACTOR XA; GLUCOSAMINE; HEPARIN, LOW-MOLECULAR-WEIGHT; IDURONIC ACID; KINETICS; PROTEASE INHIBITORS; PROTEIN BINDING; SPECTROMETRY, FLUORESCENCE; SULFURIC ACIDS;

EID: 0346100479     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815633     Document Type: Review

References (35)

1. Hirsh J. Heparin. N Engl J Med 1991;324:1565-1574
2. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991;60:443-475
3. Casu B, Lindahl U. Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 2001;57:159-206
4. Rosenberg RD, Lam L. Correlation between structure and function of heparin. Proc Natl Acad Sci U S A 1979;76:1218-1222
5. Gettings PGW, Patson PA, Olson ST. Serpins: Structure, Function and Biology. Austin, TX: RG Landes; 1996
6. Desai RU, Petitou M, Bjork I, Olson ST. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. Biochemistry 1998;37:13033-13041
7. Carrell RW, Evans DL, Stein PE. Mobile reactive centre of serpins and the control of thrombosis. Nature 1991;353:576-578
8. Huntington JA, Olson ST, Fan B, Gettins PGW. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding. Biochemistry 1996;35:8495-8503
9. Lin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A 1997;94:14683-14688
10. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl 2002;41:391-412
11. Casu B, Oreste P, Torri G, et al. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic- resonance studies. Biochem J 1981;197:599-609
12. Lindahl U, Backstrom G, Hook M, Thunberg L, Fransson LA, Linker A. Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci U S A 1979;76:3198-3202
13. Atha DH, Lormeau JC, Petitou M, Rosenberg RD, Choay J. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. Biochemistry 1987;26:6454-6461
14. Torri G, Casu B, Gatti G, et al. Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue. Biochem Biophys Res Commun 1985;128:134-140
15. Lei PS, Duchaussoy P, Sizun P, Mallet JM, Petitou M, Winay P. Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence. Bioorg Med Chem 1998;6:1337-1346
16. Casu B, Naggi A, Torri G. Modulation of sulfation patterns of glycosaminoglycans. In: Thiem J, ed. Glycoscience. Heidelberg: Springer Verlag; 2000:1895-1904
17. Naggi A, Decristofano B, Bisio A, Torri G, Casu B. Generation of antifactor Xa active 3O-sulfated glucosamine rich sequences by controlled desulfation of oversulfated heparins. Carbohydr Res 2001;336:283-290
18. Naggi A, Torri G, Casu B, et al. Supersulfated heparin fragments, a new type of low-molecular weight heparin. Physicochemical and pharmacological properties. Biochem Pharmacol 1987;36:1895-1900
19. Nordenman B, Nystrom C, Björk I. The size and shape of human and bovine antithrombin III. Eur J Biochem 1977;78:195-203
20. Olson ST. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin. J Biol Chem 1988;263:1698-1708
21. Jesty J, Esnouf MP. The preparation of activated factor X and its action on prothrombin. Biochem J 1973;131:791-799
22. Olson ST, Björk I, Shore JD. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol 1993;22:525-559
23. Manning GS. Radius of the elastic rod model of a polyelectrolyte. Biopolymers 1972;11:937-949
24. Olson ST, Halvorson HR, Björk I. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. J Biol Chem 1991;266:6342-6352
25. Evans SA, Olson ST, Shore JD. p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases. J Biol Chem 1982;257:3014-3017
26. Einarsson R, Andersson LO. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. Biochim Biophys Acta 1976;490:104-111
27. Dunn MJ, Waker JM, eds. In: The Protein Protocols Handbook. Totowa, NJ: Humana Press; 1996;229-234
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685
29. Einarsson R, Andersson LO. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. Biochim Biophys Acta 1976;490:104-111
30. Sissi C, Naggi A, Torri G, Palumbo M. Effects of sulfation on antithrombin-thrombin/Factor Xa interactions in semisynthetic low-molecular-weight heparins Semin Thromb Hemost 2001;27:483-487
31. Ersdal-Badju E, Lu A, Zuo Y, Picard V, Bock SC. Identification of the antithrombin III heparin binding site. J Biol Chem 1997;272:19393-19400
32. 2+ ions on the interactions between antithrombin III and factor Xa mediated by variously-sulfated semi-synthetic low-molecular-weight heparins Semin Thromb Hemost 2002;28:355-360
33. Evington JRN, Feldman PA, Luscombe M, Holbrook JJ. Multiple complexes of thrombin and heparin. Biochim Biophys Acta 1986;871:85-92
34. Rezaie AR. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa. J Biol Chem 1998;273:16824-16827
35. Petitou M, Herault JP, Bernat A, et al. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 1999;398:417-422